rethinkPeptides Search
Menu
Study breakdown

Toxins in Disguise: How Venom Peptides Evolved to Mimic Neuropeptides for Prey Manipulation

evidence
The takeaway

Many animal venoms contain peptides that evolved to mimic endogenous neuropeptides (insulin, oxytocin, vasopressin, somatostatin), hijacking prey physiology through molecular mimicry — providing drug design templates.

Evolution's drug lab

Venomous animals evolved peptides that mimic prey hormones with precision — millions of years of natural drug optimization available for pharmaceutical exploitation

What the researchers found

Animal venoms contain neuropeptide mimics (insulin, oxytocin, vasopressin, somatostatin analogs) evolved through molecular mimicry, providing naturally optimized drug design templates.

Why it matters

Evolution has spent millions of years optimizing venom peptides to interact with the same receptors targeted by human drugs — free drug design from nature.

How the study worked

Review of neuropeptide mimicry across animal venoms, covering evolutionary origins, molecular mechanisms, and drug design implications.

What this study cannot tell us

Review. Not all venom mimics are directly translatable to drugs. Species-specific interactions may not apply to humans.

How to read the evidence

Review of evolutionary neuropeptide mimicry with drug design implications.

When this study was published

Published in 2025.

The bigger picture

Venom peptides that mimic neuropeptides represent evolution's drug design laboratory — millions of years of optimization for receptor binding and selectivity.

Questions still open

  • Which venom neuropeptide mimic is closest to clinical development?
  • Could cone snail insulin mimics inspire faster-acting insulin analogs?
  • Do venom mimics offer selectivity advantages over synthetic peptide drugs?

Common questions

Why do venoms mimic human hormones?
Venomous animals evolved peptides that look like prey hormones to manipulate prey physiology — causing hypoglycemia (insulin mimics), paralysis (vasopressin mimics), or other incapacitation.
How does this help drug development?
These venom peptides have been naturally optimized over millions of years to bind specific receptors. They provide ready-made templates for designing new drugs that target the same receptors.

Read the original research

Toxins in disguise: Neuropeptide mimicry across animal venoms.

General and comparative endocrinology, 377, 114886

Citation

Koch, Thomas Lund; Safavi-Hemami, Helena. (2026). Toxins in disguise: Neuropeptide mimicry across animal venoms.. General and comparative endocrinology, 377, 114886. https://doi.org/10.1016/j.ygcen.2026.114886